Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details)

v3.22.4
SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Dec. 07, 2021
Dec. 31, 2021
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Nov. 08, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Nov. 09, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares authorized and reserved for future issuance (in shares)                   31,900,000
Lower exercise price (in usd per share)             $ 8.36      
Upper exercise price (in usd per share)             $ 14.00      
Granted (in shares)             2,579,167      
Period to comply with minimum personal investment requirement             5 years      
Noncash stock compensation expense   $ 4,821 $ 4,963 $ 8,396 $ 7,551 $ 156 $ 14,649   $ 0  
Unrecognized compensation expense             26,000      
Compensation expense recognized   4,821       $ 156 14,649   $ 0  
Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum personal investment requirement             2,200      
Director                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum personal investment requirement             $ 1,500      
Stock Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Expiration period             10 years      
Noncash stock compensation expense   3,600         $ 14,600      
Tax benefit recognized             $ 1,500 $ 300    
Period for recognition             1 year 10 months 24 days      
Bridge Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)             245,004      
Target EBITDA             $ 136,000      
5-Year Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)             11,097,917      
Award vesting period             5 years      
5-Year Option | Tranche One                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum compounded annual growth             13.50%      
Percent vested             25.00%      
5-Year Option | Tranche Two                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Minimum compounded annual growth             23.50%      
Percent vested             100.00%      
Common Stock | Consultant                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Awards granted in period (in shares) 100,000                  
Grant date fair value (in usd per share) $ 11.75                  
Compensation expense recognized   $ 1,200